Orion Oyj
Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.
ORNAV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009014377 (+1 more)
- LEI:
- 74370029VAHCXDR7B745
- Country:
- Finland
- Address:
- Orionintie 1, FI-02200 ESPOO
- Website:
- https://www.orion.fi/en/
- Sector:
- Manufacturing
Description
Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2007-11-13 17:38 |
Orion haastaa oikeuteen Sun Pharmaceuticals -yhtiöt Yhdysvalloissa
puolustaaks…
|
Finnish | HTML • 2.8 KB | ||
| 2007-11-07 07:30 |
171,347 Orion A-shares converted into B-shares
|
English | HTML • 793 bytes | ||
| 2007-11-07 07:30 |
171.347 Orionin A-osaketta muunnettu B-osakkeiksi
|
Finnish | HTML • 726 bytes | ||
| 2007-10-24 09:08 |
Orion Corporation s publication schedules for financial reporting in
2008
|
English | HTML • 2.1 KB | ||
| 2007-10-24 09:08 |
Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2008
|
Finnish | HTML • 2.1 KB | ||
| 2007-10-24 09:01 |
Orion Group Interim Report 1-9/2007
|
English | PDF • 138.4 KB | ||
| 2007-10-24 09:00 |
Orion-konsernin osavuosikatsaus kaudelta 1-9/2007
|
Finnish | PDF • 136.0 KB | ||
| 2007-10-01 16:28 |
Orion comments on ANDA filing of generic versions of Orion s
proprietary drug …
|
English | HTML • 3.4 KB | ||
| 2007-10-01 16:27 |
Orion kommentoi alkuperälääke Stalevon® geneeristä versiota koskevaa
USA:n myy…
|
Finnish | HTML • 3.0 KB | ||
| 2007-09-13 18:17 |
Orion sues generic drug companies in the U.S. to enforce patents for
entacapon…
|
English | HTML • 3.0 KB | ||
| 2007-09-13 18:17 |
Orion haastaa oikeuteen geneeristen lääkkeiden yhtiöitä
Yhdysvalloissa puolust…
|
Finnish | HTML • 2.8 KB | ||
| 2007-09-11 13:03 |
New President and CEO for Orion Corporation as of 1 January 2008
|
English | JPG • 941.0 KB | ||
| 2007-09-11 13:03 |
Orion Oyj:n toimitusjohtaja vaihtuu 1.1.2008
|
Finnish | JPG • 941.0 KB | ||
| 2007-08-31 07:01 |
398,000 Orion A-shares converted into B-shares
|
English | HTML • 791 bytes | ||
| 2007-08-31 07:01 |
398.000 Orionin A-osaketta muunnettu B-osakkeiksi
|
Finnish | HTML • 732 bytes |
Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orion Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orion Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
